Cargando…

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndiaye, Papa Diogop, Dufies, Maeva, Giuliano, Sandy, Douguet, Laetitia, Grépin, Renaud, Durivault, Jérôme, Lenormand, Philippe, Glisse, Natacha, Mintcheva, Janita, Vouret-Craviari, Valérie, Mograbi, Baharia, Wurmser, Maud, Ambrosetti, Damien, Rioux-Leclercq, Nathalie, Maire, Pascal, Pagès, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376471/
https://www.ncbi.nlm.nih.gov/pubmed/30809300
http://dx.doi.org/10.7150/thno.27794
_version_ 1783395565443219456
author Ndiaye, Papa Diogop
Dufies, Maeva
Giuliano, Sandy
Douguet, Laetitia
Grépin, Renaud
Durivault, Jérôme
Lenormand, Philippe
Glisse, Natacha
Mintcheva, Janita
Vouret-Craviari, Valérie
Mograbi, Baharia
Wurmser, Maud
Ambrosetti, Damien
Rioux-Leclercq, Nathalie
Maire, Pascal
Pagès, Gilles
author_facet Ndiaye, Papa Diogop
Dufies, Maeva
Giuliano, Sandy
Douguet, Laetitia
Grépin, Renaud
Durivault, Jérôme
Lenormand, Philippe
Glisse, Natacha
Mintcheva, Janita
Vouret-Craviari, Valérie
Mograbi, Baharia
Wurmser, Maud
Ambrosetti, Damien
Rioux-Leclercq, Nathalie
Maire, Pascal
Pagès, Gilles
author_sort Ndiaye, Papa Diogop
collection PubMed
description Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the lymphatic network is dependent on vascular endothelial growth factor C (VEGFC) and lies at the front line of metastatic spreading. Here, we addressed the role of VEGFC in RCC aggressiveness and the regulation of its expression in hypoxia. Methods: Transcriptional and post transcriptional regulation of VEGFC expression was evaluated by qPCR and with reporter genes. The involvement of HIF was evaluated using a siRNA approach. Experimental RCC were performed with immuno-competent/deficient mice using human and mouse cells knocked-out for the VEGFC gene by a CRISPR/Cas9 method. The VEGFC axis was analyzed with an online available data base (TCGA) and using an independent cohort of patients. Results: Hypoxia induced VEGFC protein expression but down-regulated VEGFC gene transcription and mRNA stability. Increased proliferation, migration, over-activation of the AKT signaling pathway and enhanced expression of mesenchymal markers characterized VEGFC-/- cells. VEGFC-/- cells did not form tumors in immuno-deficient mice but developed aggressive tumors in immuno-competent mice. These tumors showed down-regulation of markers of activated lymphocytes and M1 macrophages, and up-regulation of M2 macrophages markers and programmed death ligand 1 (PDL1). Over-expression of lymphangiogenic genes including VEGFC was linked to increased disease-free and overall survival in patients with non-metastatic tumors, whereas its over-expression correlated with decreased progression-free and overall survival of metastatic patients. Conclusion: Our study revisited the admitted dogma linking VEGFC to tumor aggressiveness. We conclude that targeting VEGFC for therapy must be considered with caution.
format Online
Article
Text
id pubmed-6376471
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-63764712019-02-26 VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness Ndiaye, Papa Diogop Dufies, Maeva Giuliano, Sandy Douguet, Laetitia Grépin, Renaud Durivault, Jérôme Lenormand, Philippe Glisse, Natacha Mintcheva, Janita Vouret-Craviari, Valérie Mograbi, Baharia Wurmser, Maud Ambrosetti, Damien Rioux-Leclercq, Nathalie Maire, Pascal Pagès, Gilles Theranostics Research Paper Hypoxic zones are common features of metastatic tumors. Due to inactivation of the von Hippel-Lindau gene (VHL), renal cell carcinomas (RCC) show constitutive stabilization of the alpha subunit of the hypoxia-inducible factor (HIF). Thus, RCC represents a model of chronic hypoxia. Development of the lymphatic network is dependent on vascular endothelial growth factor C (VEGFC) and lies at the front line of metastatic spreading. Here, we addressed the role of VEGFC in RCC aggressiveness and the regulation of its expression in hypoxia. Methods: Transcriptional and post transcriptional regulation of VEGFC expression was evaluated by qPCR and with reporter genes. The involvement of HIF was evaluated using a siRNA approach. Experimental RCC were performed with immuno-competent/deficient mice using human and mouse cells knocked-out for the VEGFC gene by a CRISPR/Cas9 method. The VEGFC axis was analyzed with an online available data base (TCGA) and using an independent cohort of patients. Results: Hypoxia induced VEGFC protein expression but down-regulated VEGFC gene transcription and mRNA stability. Increased proliferation, migration, over-activation of the AKT signaling pathway and enhanced expression of mesenchymal markers characterized VEGFC-/- cells. VEGFC-/- cells did not form tumors in immuno-deficient mice but developed aggressive tumors in immuno-competent mice. These tumors showed down-regulation of markers of activated lymphocytes and M1 macrophages, and up-regulation of M2 macrophages markers and programmed death ligand 1 (PDL1). Over-expression of lymphangiogenic genes including VEGFC was linked to increased disease-free and overall survival in patients with non-metastatic tumors, whereas its over-expression correlated with decreased progression-free and overall survival of metastatic patients. Conclusion: Our study revisited the admitted dogma linking VEGFC to tumor aggressiveness. We conclude that targeting VEGFC for therapy must be considered with caution. Ivyspring International Publisher 2019-01-21 /pmc/articles/PMC6376471/ /pubmed/30809300 http://dx.doi.org/10.7150/thno.27794 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Ndiaye, Papa Diogop
Dufies, Maeva
Giuliano, Sandy
Douguet, Laetitia
Grépin, Renaud
Durivault, Jérôme
Lenormand, Philippe
Glisse, Natacha
Mintcheva, Janita
Vouret-Craviari, Valérie
Mograbi, Baharia
Wurmser, Maud
Ambrosetti, Damien
Rioux-Leclercq, Nathalie
Maire, Pascal
Pagès, Gilles
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title_full VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title_fullStr VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title_full_unstemmed VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title_short VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
title_sort vegfc acts as a double-edged sword in renal cell carcinoma aggressiveness
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376471/
https://www.ncbi.nlm.nih.gov/pubmed/30809300
http://dx.doi.org/10.7150/thno.27794
work_keys_str_mv AT ndiayepapadiogop vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT dufiesmaeva vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT giulianosandy vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT douguetlaetitia vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT grepinrenaud vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT durivaultjerome vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT lenormandphilippe vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT glissenatacha vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT mintchevajanita vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT vouretcraviarivalerie vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT mograbibaharia vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT wurmsermaud vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT ambrosettidamien vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT riouxleclercqnathalie vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT mairepascal vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness
AT pagesgilles vegfcactsasadoubleedgedswordinrenalcellcarcinomaaggressiveness